Categories: aggregated

Pharmaceutical Companies Win Big with Schedule 3 Classification of Cannabis – Desheduling is the Only Way for True Equity

For decades, Joe Biden has been cozy with Big Pharma, accepting millions in campaign contributions from drug companies over his long political career. It’s no secret that the pharmaceutical industry vehemently opposes cannabis legalization, as legal weed represents a major threat to their profits from opiate painkillers and other drugs. Pharma much prefers that cannabis remain illegal, or barring that, placed into a restrictive category like Schedule III that they can control and corner the market on.

Jason

Share
Published by
Jason

Recent Posts

Chile Sent 500 Police to Raid a Cannabis Patient Organization Serving 16,000 People. Prosecutors Call It Organized Crime.

Chile’s Operación Imperio Ámsterdam (Operation Amsterdam Empire, in English) mobilized more than 500 police officers…

19 hours ago

Trump Signed an Order Paying Farmers to Heal Their Soil. Weed Growers Get Nothing.

Sun-grown cannabis, living soil, and the growers building a regenerative future while federal money flows…

3 days ago

How the THC Ban Is Turning Texas Blue – Well, Purple at Least

On July 31, 2026, the Texas Department of State Health Services reinstated controlled-substance definitions it…

3 days ago

Who Are the Latino Leaders Cannabis Should Know? Nominations Open Friday for the First Latino Power 100.

A new annual list will name 100 Latino and Hispanic leaders shaping cannabis around the…

4 days ago